Passa al contenuto
Merck

Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers.

Human mutation (2006-08-31)
Laura D Wood, Eric S Calhoun, Natalie Silliman, Janine Ptak, Steve Szabo, Steve M Powell, Gregory J Riggins, Tian-Li Wang, Hai Yan, Adi Gazdar, Scott E Kern, Len Pennacchio, Kenneth W Kinzler, Bert Vogelstein, Victor E Velculescu
ABSTRACT

Tyrosine kinases are major regulators of signal transduction cascades involved in cellular proliferation and have important roles in tumorigenesis. We have recently analyzed the tyrosine kinase gene family for alterations in human colorectal cancers and identified somatic mutations in seven members of this gene family. In this study we have used high-throughput sequencing approaches to further evaluate this subset of genes for genetic alterations in other human tumors. We identified somatic mutations in GUCY2F, EPHA3, and NTRK3 in breast, lung, and pancreatic cancers. Our results implicate these tyrosine kinase genes in the pathogenesis of other tumor types and suggest that they may be useful targets for diagnostic and therapeutic intervention in selected patients.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
EPHA3 (571-end), active, GST tagged human, PRECISIO® Kinase, recombinant, expressed in baculovirus infected Sf9 cells, ≥70% (SDS-PAGE), buffered aqueous glycerol solution